Bardy Diagnostics is a company manufacturing an ambulatory cardiac patch for remote monitoring. It develops Carnation Ambulatory Monitor (CAM). The Company's product monitors patients' cardiac activity and detects arrhythmia over a seven-day period.
|Employees (est.) (Sept 2020)||122||(+8%)|
Bardy Diagnostics total Funding
Bardy Diagnostics latest funding size
Time since last funding
|a year ago|
Bardy Diagnostics investors
|Health Enterprise Partners, Square 1 Bank, River Cities Capital Funds, SV Life Sciences, Ascension Ventures, Aperture Venture Partners, Aphelion Capital, Rex Health Ventures, HealthQuest Capital, SV Health Investors, Lumira Ventures|
Bardy Diagnostics has 1.3k Twitter Followers. The number of followers has increased 0.7% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Bardy Diagnostics founded?
Bardy Diagnostics was founded in 2013.
Who are Bardy Diagnostics key executives?
Bardy Diagnostics's key executives are Gust H. Bardy, Mark Handfelt and Mark Querry.
How many employees does Bardy Diagnostics have?
Bardy Diagnostics has 122 employees.
Who are Bardy Diagnostics competitors?
Competitors of Bardy Diagnostics include CDx Diagnostics, Hound Labs and iScreen Vision.
Where is Bardy Diagnostics headquarters?
Bardy Diagnostics headquarters is located at 316 Occidental Ave S B310, Seattle.
Where are Bardy Diagnostics offices?
Bardy Diagnostics has offices in Seattle, Houston, New Providence and Chicago.
How many offices does Bardy Diagnostics have?
Bardy Diagnostics has 4 offices.
Receive alerts for 300+ data fields across thousands of companies